ClinicalTrials.govpublic full text
Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock
aging, obesity & overweight, linage2, biological age, glp-1 receptor agonist, semaglutide, tirzepatide, weight management program, lifestyle, real-world evidence, cardiometabolic biomarkers, body composition
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 907004
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.